TOLNAFTATE 1% and PNEUMONIA

Overview

PNEUMONIA is the #5 most commonly reported adverse reaction for TOLNAFTATE 1%, manufactured by Meijer Distribution Inc. There are 14 FDA adverse event reports linking TOLNAFTATE 1% to PNEUMONIA. This represents approximately 1.9% of all 724 adverse event reports for this drug.

Patients taking TOLNAFTATE 1% who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PNEUMONIA is a less commonly reported adverse event for TOLNAFTATE 1%, but still significant enough to appear in the safety profile.

Other Side Effects of TOLNAFTATE 1%

In addition to pneumonia, the following adverse reactions have been reported for TOLNAFTATE 1%:

• DIARRHOEA — 23 reports
• ARTHRALGIA — 17 reports
• DYSPNOEA — 16 reports
• DRUG INEFFECTIVE — 14 reports
• BLOOD POTASSIUM INCREASED — 13 reports
• GASTROINTESTINAL DISORDER — 13 reports
• HEADACHE — 13 reports
• RASH ERYTHEMATOUS — 13 reports
• BRONCHOPULMONARY ASPERGILLOSIS — 12 reports
• MUCORMYCOSIS — 12 reports

Other Drugs Associated with PNEUMONIA

The following drugs have also been linked to pneumonia in FDA adverse event reports:

Does TOLNAFTATE 1% cause PNEUMONIA?

PNEUMONIA has been reported as an adverse event in 14 FDA reports for TOLNAFTATE 1%. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PNEUMONIA with TOLNAFTATE 1%?

PNEUMONIA accounts for approximately 1.9% of all adverse event reports for TOLNAFTATE 1%, making it a notable side effect.

What should I do if I experience PNEUMONIA while taking TOLNAFTATE 1%?

If you experience pneumonia while taking TOLNAFTATE 1%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages